Barclays’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-489
| Closed | -$21K | – | 3982 |
|
|
2021
Q3 | $21K | Sell |
489
-324
| -40% | -$13.9K | ﹤0.01% | 3626 |
|
|
2021
Q2 | $34K | Sell |
813
-1,955
| -71% | -$81.8K | ﹤0.01% | 3560 |
|
|
2021
Q1 | $134K | Buy |
2,768
+851
| +44% | +$41.2K | ﹤0.01% | 3279 |
|
|
2020
Q4 | $188K | Sell |
1,917
-221
| -10% | -$21.7K | ﹤0.01% | 2723 |
|
|
2020
Q3 | $148K | Sell |
2,138
-882
| -29% | -$61.1K | ﹤0.01% | 2878 |
|
|
2020
Q2 | $319K | Buy |
3,020
+1,096
| +57% | +$116K | ﹤0.01% | 2570 |
|
|
2020
Q1 | $171K | Sell |
1,924
-847
| -31% | -$75.3K | ﹤0.01% | 2615 |
|
|
2019
Q4 | $316K | Buy |
2,771
+590
| +27% | +$67.3K | ﹤0.01% | 2944 |
|
|
2019
Q3 | $134K | Sell |
2,181
-1,443
| -40% | -$88.7K | ﹤0.01% | 3246 |
|
|
2019
Q2 | $283K | Buy |
3,624
+2,672
| +281% | +$209K | ﹤0.01% | 3014 |
|
|
2019
Q1 | $128K | Buy |
952
+116
| +14% | +$15.6K | ﹤0.01% | 3224 |
|
|
2018
Q4 | $67K | Sell |
836
-361
| -30% | -$28.9K | ﹤0.01% | 3097 |
|
|
2018
Q3 | $125K | Buy |
1,197
+804
| +205% | +$84K | ﹤0.01% | 3298 |
|
|
2018
Q2 | $40K | Sell |
393
-548
| -58% | -$55.8K | ﹤0.01% | 3369 |
|
|
2018
Q1 | $118K | Sell |
941
-1,159
| -55% | -$145K | ﹤0.01% | 3095 |
|
|
2017
Q4 | $352K | Buy |
2,100
+907
| +76% | +$152K | ﹤0.01% | 2325 |
|
|
2017
Q3 | $376K | Buy |
1,193
+418
| +54% | +$132K | ﹤0.01% | 2074 |
|
|
2017
Q2 | $229K | Sell |
775
-995
| -56% | -$294K | ﹤0.01% | 2375 |
|
|
2017
Q1 | $409K | Buy |
+1,770
| New | +$409K | ﹤0.01% | 2076 |
|
|
2016
Q3 | – | Sell |
-72
| Closed | -$5K | – | 4122 |
|
|
2016
Q2 | $5K | Buy |
+72
| New | +$5K | ﹤0.01% | 3130 |
|
|
2015
Q4 | – | Sell |
-3
| Closed | – | – | 3903 |
|
|
2015
Q3 | $0 | Sell |
3
-8
| -73% | – | ﹤0.01% | 4187 |
|
|
2015
Q2 | $1K | Sell |
11
-1
| -8% | -$91 | ﹤0.01% | 4031 |
|
|
2015
Q1 | $4K | Sell |
12
-21
| -64% | -$7K | ﹤0.01% | 3782 |
|
|
2014
Q4 | $13K | Buy |
+33
| New | +$13K | ﹤0.01% | 3630 |
|